The FDA is asking for public comments on how to reclassify weed
If you're the kind of person who's spent the better part of the past two years bitching and moaning to complete strangers on VICE comment threads about the misdoings of justice in America, it's high time to take those weed-related rants elsewhere.
Because right now (or at least until April 23, 2018) the FDA is seeking public comments on what exactly the organization should do about cannabis and its archaic classification next to heroin and date rape drugs (but not meth or cocaine, for some strange reason).
Per the site's summary, The Food and Drug Administration is "requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of five drug substances."
That is, it wants to try and figure out what the future holds for the cannabis plant and its resin; extracts and tinctures of cannabis; delta-9-tetrahydrocannabinol (THC; stereoisomers of THC; and cannabidiol (CBD).
It's likely best not to read too much into something of this nature, as it's done this very thing in the past. However, it could be a small glimpse into what the future for America holds. Just recently, former Republican House Speaker John Boehner flipped on his anti-weed stance, and even stalwart Mitch McConnell introduced legislation to classify hemp as an agricultural asset rather than a dangerous plant. The right has finally found value in it, so it appears momentum is on the side of full legalization real, real soon. (Sorry Sessions.)
FULL FDA SUMMARY:
The Food and Drug Administration (FDA) is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of five drug substances. These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs. This notice requesting comments is required by the Controlled Substances Act (the CSA).